|
시장보고서
상품코드
2075974
리보핵산(RNA) 마커 시장 : 유형별, 용도별, 최종 사용자별, 지역별Ribonucleic Acid (RNA) Markers Market, by Type, by Application, by End User by Region |
||||||
리보핵산(RNA) 마커 시장은 2026년에 2억 9,260만 달러 규모로 추정되며, 2033년까지 5억 3,340만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 9.0%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 2억 9,260만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 9.00% | 시장 규모 예측(2033년) : | 5억 3,340만 달러 |
분자 마커(유전 마커라고도 함)란, 유전체 또는 RNA 풀 내의 특정 위치와 연관된 DNA 또는 RNA 단편을 말합니다. 분자 마커는 분자생물학 및 생명공학 분야에서 미지의 핵산 서열 풀 중에서 특정 DNA 또는 RNA 서열을 식별하는 데 사용됩니다. RNA 마커는 단일 가닥 RNA의 크기를 추정하는 데 사용됩니다. 예를 들어, 생명공학 및 분자생물학 분야용 효소 및 기타 제품을 제조하는 프로메가(Promega)사는 RNA 마커를 제공하고 있으며, 이 마커들은 글리옥살 또는 포름알데히드 아가로스 겔에서 0.28-6.58kb 크기의 단일 가닥 RNA의 크기 추정용으로 적합합니다. RNA 마커는 특정 템플릿을 사용하여 시험관 내에서 합성된 9개의 RNA 전사 산물로 구성된 래더로 이루어져 있습니다. 그 크기는 281, 623, 955, 1, 383, 1, 908, 2, 604, 3, 638, 4, 981 및 6,583 염기입니다. 이러한 마커는 에티디움 브로마이드 염색을 통해 시각화할 수 있습니다.
시장 역학
시장에 진출한 각 기업은 제조 시설 확장에 주력하고 있으며, 이는 예측 기간 동안 세계 리보핵산(RNA) 마커 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2023년 1월 20일, 미국에 본사를 둔 제약 및 바이오기술 기업인 Moderna, Inc.는 팬데믹 대응 체계를 강화하기 위해 캐나다 정부와의 10년간 파트너십의 일환으로 캐나다 내 생산 능력 확대를 계획하고 있습니다. 또한, 이 회사는 위와 같은 이유로 호주 내 제조 시설의 확장도 계획하고 있습니다. 또한, 이 회사는 케냐에 있는 제조 시설을 확장할 계획입니다. 호주의 시설에서는 호흡기 감염증용 mRNA 백신을 포함해 연간 최대 1억 회분을 생산할 것으로 예측됩니다. 케냐의 새로운 시설에서는 연간 최소 5억 회분의 백신을 생산할 것으로 예측됩니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 세계 리보핵산(RNA) 마커 시장의 주요 기업을 분석했습니다. 본 조사에서 다루고 있는 주요 기업으로는 Agilent Technologies, Inc., Oxford Gene Technology IP Limited, PerkinElmer Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, NextGen Life Sciences Private Limited, bioMerieux SA, New England Biolabs, Promega Corporation, Merck KGaA, Takara Bio Inc., Abnova Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Bio-Rad Laboratories, Inc., Lonza, CardioNet, ZOLL Medical Corporation 및 Hill-Rom Services, Inc입니다.
- 본 보고서의 인사이트를 활용함으로써, 각 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 세계의 리보핵산(RNA) 마커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 리보핵산(RNA) 마커 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 리보핵산(RNA) 마커 시장 : 유형별(2021-2033년)
제5장 세계의 리보핵산(RNA) 마커 시장 : 용도별(2021-2033년)
제6장 세계의 리보핵산(RNA) 마커 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 리보핵산(RNA) 마커 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJY 26.07.09Ribonucleic Acid (RNA) Markers Market is estimated to be valued at USD 292.6 Mn in 2026 and is expected to reach USD 533.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 292.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.00% | 2033 Value Projection: | USD 533.4 Mn |
A molecular marker (identified as genetic marker) is a fragment of DNA or RNA, which is associated with a certain location within the genome or RNA Pool. Molecular markers are used in molecular biology and biotechnology to identify a particular sequence of DNA or RNA in a pool of unknown nucleic acid sequence. RNA markers are used for the size estimation of single stranded RNA. For example, Promega Corporation, manufacturer of enzymes and other products for biotechnology and molecular biology is offering RNA markers and these markers are suitable for size estimation of single-stranded RNA from 0.28-6.58kb in glyoxal or formaldehyde-agarose gels. The RNA markers consist of a ladder of nine RNA transcripts that are synthesized in vitro from specific templates. The sizes are 281, 623, 955, 1,383, 1,908, 2,604, 3,638, 4,981 and 6,583 bases. The markers can be visualized by ethidium bromide staining.
Market Dynamics
Market players are indulged in expansion of manufacturing facilities, which is expected to drive the growth of the global ribonucleic acid (RNA) markers market, over the forecast period. For instance, on 20 January 2023, Moderna, Inc., an U.S. based pharmaceutical and biotechnology company, is planning to expand its manufacturing capacity in Canada, as part of a 10-year partnership with the Canadian government in order to strengthen the company's pandemic response. Moreover, the company is also planning to expand its manufacturing facility in Australia, for the same reason as above. The company is also planning to expand its manufacturing facility in Kenya. The Australian facility is expected to produce up to 100 million mRNA vaccine doses annually, including for respiratory infections. The new facility in Kenya is expected to produce at least of 500 million vaccine doses per year.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global ribonucleic acid (RNA) markers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Agilent Technologies, Inc., Oxford Gene Technology IP Limited, PerkinElmer Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, NextGen Life Sciences Private Limited, bioMerieux SA, New England Biolabs, Promega Corporation, Merck KGaA, Takara Bio Inc., Abnova Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Bio-Rad Laboratories, Inc., Lonza, CardioNet, ZOLL Medical Corporation and Hill-Rom Services, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global ribonucleic acid (RNA) markers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ribonucleic acid (RNA) markers market
Detailed Segmentation:
- Global Ribonucleic Acid (RNA) Markers Market, By Type (Revenue, USD Mn, 2021 - 2033)
- Prestained Markers
- Unstained Markers
- Specialty Markers
- Global Ribonucleic Acid (RNA) Markers Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Nucleic Acid Applications
- Proteomics Applications
- Global Ribonucleic Acid (RNA) Markers Market By End User (Revenue, USD Mn, 2021 - 2033)
- Research Centers
- Pharmaceutical and Biotechnology Companies
- Others ( Academic Institutes, Forensic Laboratory and Others)
- Global Ribonucleic Acid (RNA) Markers Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Agilent Technologies, Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oxford Gene Technology IP Limited
- PerkinElmer Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
- NextGen Life Sciences Private Limited
- bioMerieux SA
- New England Biolabs
- Promega Corporation
- Merck KGaA
- Takara Bio Inc.
- Abnova Corporation
- Thermo Fisher Scientific Inc.
- QIAGEN
- Bio-Rad Laboratories, Inc.
- Lonza, CardioNet
- ZOLL Medical Corporation
- Hill-Rom Services, Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Market Trends
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER's Analysis
- Technology Landscape
- Pricing Analysis
- Brand Analysis
- Investments and Funding
- Facility Expansions
4. Global Ribonucleic Acid (RNA) Markers Market, By Type, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prestained Markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Unstained Markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Specialty Markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Ribonucleic Acid (RNA) Markers Market, By Application, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Nucleic Acid Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Proteomics Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Ribonucleic Acid (RNA) Markers Market, By End User, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others ( Academic Institutes, Forensic Laboratory and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Ribonucleic Acid (RNA) Markers Market, By Region, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Oxford Gene Technology IP Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NextGen Life Sciences Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CardioNet
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ZOLL Medical Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hill-Rom Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
